Redmile Group, LLC
Q3 2025 13F Holdings
- Locationsan francisco, CA
- Num holdings
40
- Value ($000)
$1,027,816
- Date Filed11/14/2025
- Form type13F-HR
- CIK0001425738
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q3 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
SCHOLAR ROCK HLDG CORP | COM | 80706P103 | $145.4M | 14 % | 3,904,456 | ||
KRYSTAL BIOTECH INC | COM | 501147102 | $116.75M | 11 % | 661,388 | ||
STOKE THERAPEUTICS INC | COM | 86150R107 | $98.13M | 10 % | 4,175,542 | ||
ZYMEWORKS INC | COM | 98985Y108 | $63.29M | 6 % | 3,705,750 | ||
ADC THERAPEUTICS SA | SHS | H0036K147 | $62.67M | 6 % | 15,666,731 | ||
IMMUNOME INC | COM | 45257U108 | $58.82M | 6 % | 5,023,385 | ||
LIVANOVA PLC | SHS | G5509L101 | $48.55M | 5 % | 926,799 | ||
REGENXBIO INC | COM | 75901B107 | $45.29M | 4 % | 4,693,389 | ||
AKERO THERAPEUTICS INC | COM | 00973Y108 | $35.51M | 4 % | 747,818 | ||
NURIX THERAPEUTICS INC | COM | 67080M103 | $33.99M | 3 % | 3,678,394 |
Rows Per Page
10
- 5
- 10
- 20
- 30
- 50
- 100